Insiders KALA BIO, Inc.

Equities

KALA

US4831192020

Market Closed - Nasdaq Other stock markets 21:30:01 10/05/2024 BST			5-day change	1st Jan Change
6.9 ^USD	+2.79%		-1.53%	-1.43%

04-02	HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating	MT
03-29	KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kala Pharmaceuticals Changes Name to Kala Bio	02/08/23	MT
Kala Pharmaceuticals, Inc. Announces Robert Paull Not Stands for Re-Election as A Director	11/05/23	CI
Kala Pharmaceuticals, Inc. Appoints Francis Mah as Chief Medical Advisor	29/03/23	CI
Kala Pharmaceuticals, Inc. Announces Appointment of Marjan Farid to Its Board of Directors	01/11/22	CI
Kala Pharmaceuticals, Inc. Appoints Todd Bazemore as President	20/12/21	CI
Kala Pharmaceuticals, Inc. Announces Executive Appointments	15/11/21	CI
Kala Pharmaceuticals Announces Board of Directors Changes	18/10/21	CI
Kala Pharmaceuticals, Inc Announces Resignation of Robert S. Langer as Member of the Board of Directors	20/12/18	CI
Kala Pharmaceuticals, Inc. Announces Resignation of Paulina Hill as A Member of the Board of Directors and Member of the Audit Committee	01/11/18	CI
Kala Pharmaceuticals, Inc. Appoints Steven Zhang as Vice President of Medical Affairs	25/10/18	CI
Kala Pharmaceuticals, Inc. Announces Executive Appointments	09/05/18	CI
Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary	03/04/18	CI
Kala Pharmaceuticals, Inc. Appoints Gregory Perry as Class I Director	05/03/18	CI
Kala Pharmaceuticals, Inc. Appoints Todd Bazemore as Chief Operating Officer, Effective on or About November 20, 2017	13/11/17	CI
Kala Pharmaceuticals, Inc. Appoints Andrew I. Koven to Board of Directors	02/10/17	CI
Kala Pharmaceuticals, Inc. Announces Executive Changes	11/08/17	CI
Kala Pharmaceuticals, Inc. Announces Board Appointments	13/04/16	CI
Kala Pharmaceuticals Inc Appoints Mark Iwicki as Executive Chairman and Member of the Board of Directors	23/06/15	CI
Kala Pharmaceuticals, Inc. Appoints Mark Iwicki as Executive Chairman and Member of Board of Directors	14/05/15	CI
Kala Pharmaceuticals, Inc. Names Karen Wagner to its Board of Directors	23/04/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders KALA BIO, Inc.

Equities

KALA

US4831192020

Insiders

Filters